Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 204972
Company: ACTAVIS ELIZABETH
Company: ACTAVIS ELIZABETH
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TAPENTADOL | TAPENTADOL | 50MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
| TAPENTADOL | TAPENTADOL | 100MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
| TAPENTADOL | TAPENTADOL | 150MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
| TAPENTADOL | TAPENTADOL | 200MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
| TAPENTADOL | TAPENTADOL | 250MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/24/2017 | ORIG-1 | Tentative Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204972Orig1s000TAltr.pdf |